National Health Investors (NHI) Receivables - Accured (2023 - 2026)

National Health Investors has reported Receivables - Accured for 4 years, with the latest figure at $221.3 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Accured rose 79.74% year-over-year to $221.3 million; the trailing twelve-month figure through Mar 2026 stood at $221.3 million (up 79.74% YoY), and the FY2025 full-year result was $154.3 million, down 12.23% from the prior year.
• Receivables - Accured for Q1 2026 stood at $221.3 million, up from $154.3 million in the prior quarter.
• The five-year high for Receivables - Accured was $221.3 million in Q1 2026, with the low at $8.6 million in Q1 2023.
• Historically, Receivables - Accured has averaged $87.8 million across 4 years, with a median of $93.4 million in 2023.
• Annual changes were most pronounced in 2024 — Receivables - Accured plunged 84.48% — and 2025, when it jumped 651.03%.
• National Health Investors' Receivables - Accured stood at $162.4 million in 2023, then rose by 8.25% to $175.8 million in 2024, then retreated by 12.23% to $154.3 million in 2025, then soared by 43.42% to $221.3 million in 2026.
• The last three Receivables - Accured figures came in at $221.3 million (Q1 2026), $154.3 million (Q4 2025), and $108.9 million (Q3 2025), per Business Quant data.